Eligible Companies for Exchange

Route 92 is the developer of an innovative medical device aimed at treating strokes and similar conditions. Their device features a percutaneous catheter for addressing acute ischemic stroke, a rapid aspiration thrombectomy system, and a delivery system for intra-cerebral implants. This technology empowers healthcare professionals to effectively treat patients and enhance the recovery process for those overcoming a stroke.

Rula has developed a therapy platform aimed at revolutionizing mental healthcare management. The company's platform combines the freedom of private practice with comprehensive support services, including marketing, credentialing, billing, and administrative tasks. This allows providers to concentrate on delivering care. By taking a patient-first approach, Rula ensures that treatment becomes more accessible, personalized, and effective, enabling therapists to focus on what they excel at: providing essential care to those in need.

SalioGen Therapeutics has developed a genome engineering platform designed to deliver long-lasting, safe, and cost-effective non-viral gene therapies for individuals with genetic disorders. This mammal-based platform holds potential for curative non-viral gene therapy, allowing the healthcare sector to enhance processes in cell therapy, cell engineering, and biologics production for patients requiring treatment.

Santa Ana Bio, a biotechnology company, focuses on advancing precision immunology to treat autoimmune diseases. By utilizing single-cell genomics and sophisticated analytics, the company crafts personalized biologics tailored for autoimmune conditions. This approach allows patients to access targeted and effective treatments, resulting in expected outcomes and an enhanced quality of life.

Scorpion Therapeutics is a biotechnology company that aims to bring precision medicine to a larger population of cancer patients. The company combines techniques from target discovery, medicinal chemistry, and translational medicine to create a range of targeted small-molecule drugs that surpass the constraints of current treatments. By implementing a fit-to-purpose model, Scorpion Therapeutics efficiently paves the way for the future of precision oncology, empowering healthcare professionals to provide cancer patients with innovative treatment options.

Seismic Therapeutic is a biotechnology platform focused on speeding up the development of immunology drugs. By incorporating machine learning throughout the biologics discovery process, the company aims to tackle key obstacles in biologics discovery and drug development. This enables drug developers to explore innovative and faster methods for creating medicines for patients.

Selkirk Pharma operates as a contract manufacturing organization that delivers dependable aseptic fill and finish services. The company excels in producing aseptic medicine, specifically injectable drugs, using unidirectional process flows, electronic batch records, and advanced isolators and filling equipment. This allows pharmaceutical companies to have their medical equipment manufactured in a secure environment.

Sionna is a life sciences technology developer focused on creating highly effective and distinct treatments for cystic fibrosis. The company is advancing first-in-class small molecules targeting a unique pathway, aiming to fully normalize cystic fibrosis transmembrane conductance regulator (CFTR) function for the vast majority of those affected by the condition. Sionna's approach promises best-in-class efficacy, broad reach, and sustained benefits for cystic fibrosis patients.

SmarterDx has developed an automated pre-bill review platform to assist hospitals in maintaining revenue integrity. This platform automatically prioritizes diagnoses based on their financial significance to hospitals, accounting for factors like MS-DRG, 3M APR-DRG, Vizient, HCC, and Elixhauser models. By using this system, hospitals can ensure their revenue cycle teams thoroughly evaluate all relevant diagnoses, optimizing their financial outcomes.

SmithRx operates a pharmacy benefit management platform designed to emphasize transparency, efficiency, and data analytics. This platform provides employer customers and partners with maximum flexibility, control, and visibility over pharmacy benefits data. Through SmithRx's clinical programs, alternative sourcing, and transparent pricing, members can easily manage their prescription benefits and lower overall drug costs.

Somatus is a provider of concierge kidney care with a mission to delay or prevent the progression of chronic kidney disease to ESRD. The company's approach to kidney care enhances utilization of home-based dialysis for end-stage renal disease patients and slows the progression of chronic kidney disease. This enables patients to access improved outcomes through home-based dialysis treatments and increases the number of patients who qualify for and ultimately receive kidney transplants.

SonderMind is the creator of a platform for mental and behavioral health that aims to enhance the accessibility of mental health therapy and consultancy. The platform developed by the company links individuals requiring mental aid to local therapists, thereby assisting patients afflicted with anxiety, depression, and burnout to seek advice from psychologists and better their mental condition.

Sonoma Biotherapeutics develops T-cell therapies with the aim of treating autoimmune and degenerative diseases. The company's therapies work by promoting self-tolerance, which stops the damaging inflammatory responses commonly seen in autoimmune diseases like rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis. Additionally, it offers potential treatment options for degenerative diseases such as amyotrophic lateral sclerosis and Alzheimer's, thus providing physicians with new ways to combat these critical illnesses.

Spring Health operates a digital healthcare platform designed to offer personalized mental healthcare aimed at improving employee well-being. The platform harnesses assessment and machine-learning technology to identify a range of conditions a person may be dealing with and uses the results to pair them with a care plan tailored to their specific needs. Spring Health allows businesses to upgrade their behavioral health benefits with a comprehensive and effective substitute.

Strand Therapeutics delivers biotechnology services aimed at developing gene therapies through synthetic biology. The company's services focus on crafting immunotherapies that produce specific cancer-targeting proteins during treatment, allowing patients to enhance their immune response to combat cancer effectively.

Strata Oncology operates as an oncology company focused on enhancing the impact of precision medicine for cancer patients. The company collaborates with leading healthcare systems nationwide, which routinely send their cancer patients' biopsies to high-throughput CLIA-certified labs for genomic sequencing. Within days, results are delivered to the oncologist, detailing the tumor profile and identifying suitable therapies and clinical trials. This enables healthcare providers to offer actionable insights, significantly improving the lives of cancer patients.

Suki has developed a medical voice assistant designed to simplify clinical documentation and alleviate the administrative workload for healthcare professionals. This innovative platform leverages artificial intelligence and natural language processing to generate comprehensive clinical notes during or after patient consultations. By doing so, it enables doctors and surgeons to make better use of their time, mitigate burnout, and enhance both the quality of patient care and the precision of their medical records.

Syllable has developed a text and voice-based platform designed to enhance communication between patients and healthcare providers. This platform allows for seamless exchanges regarding primary care, specialist referrals, vaccinations, and general practice details, empowering patients to access healthcare information and guidance without needing to be in a clinical environment.

Synchron has developed an implantable stentrode aimed at establishing a brain-computer interface. This innovative company provides a minimally invasive device equipped with electrode arrays that decode brain signals to influence neural activity in targeted areas. This technology empowers patients with motor impairments to regain some control over digital devices, prosthetics, or other assistive technologies using just their thoughts.

Synthego has developed a precision genome engineering platform to expedite and enhance the process of drug discovery research. The platform, which integrates informatics and machine learning, introduces precision and automation to genome engineering. This innovation allows genetic engineers and healthcare practitioners to carry out research swiftly, cost-effectively, and with consistent outcomes for all scientists involved.

Synthekine develops engineered cytokine therapeutics aimed at creating disease-specific treatments. By utilizing immunological insights, the company focuses on targeted protein engineering to produce transformative medicines. This approach empowers the medical community to enhance the treatment of cancer and autoimmune disorders.

Tend is a provider of dental care services designed to offer more precise diagnoses and superior restorations. The company delivers dentistry in an uncomplicated, customized, and transparent manner, enabling patients to experience a relaxing and efficient dental appointment.

Tessera, a pioneer in gene writing technology, is designed to facilitate both minor and major modifications to the human genome. This innovative technology serves as a powerful tool for scientists and clinicians to inscribe therapeutic messages, both small and large, into the genome to address diseases at their origin. Consequently, it empowers healthcare providers to treat their patients effectively, thereby enhancing their quality of life.

Third Arc Bio is a biotech company focused on the research and development of multifunctional antibodies. Their platform aims to deliver groundbreaking therapies for solid tumors, inflammation, and immunological disorders by producing antibodies that form immune synapses for precise activation or inhibition of T cells. This enables medical companies to access advanced antibodies for treating immune system-related diseases.

Thirty Madison, a company focused on prioritizing human needs, provides personalized healthcare treatments and services tailored to meet unique community requirements. The company develops condition-specific brands that offer comprehensive care for various conditions such as hair loss, migraines, allergies, and skin conditions. This enables patients to access specialized healthcare brands that deliver exceptional results for everyone.

Thrive Global is a pioneer in behavior change technology, focusing on putting an end to the widespread stress and burnout epidemic. The company's state-of-the-art technology provides individuals and corporations with scientifically-backed services that aim to reduce stress and burnout, fostering a healthier relationship with technology. Thrive Global's services enhance both mental and physical well-being, leading to better performance, purpose, and a personal experience of health, happiness, and prosperity.

Tia is a health advisory platform operator that aims to assist all individuals in attaining their ideal health status. The platform provided by Tia offers advice on topics such as birth control and sexual health, primary care, mental health, and acupuncture. This empowers women to confidently make autonomous and informed choices regarding their bodies, health, and lives.

Tizona Therapeutics is a pioneering immunology company that aims to exploit the capabilities of the immune system for developing effective treatments for cancer and autoimmune diseases. The company's innovative treatments are engineered to regulate the operations of immunosuppressive cells by focusing on the specific cell types and biological processes that cause immune suppression within the tumor microenvironment. This approach allows Tizona Therapeutics to provide patients with comprehensive and long-lasting remission from cancer and autoimmune diseases.

TMRW Life Sciences is a pioneering fertility technology company that focuses on the secure care and management of frozen eggs and embryos. Their innovative platform revolutionizes the specimen management process by integrating technology, automation, robotics, user-friendly touchscreen software, and continuous remote monitoring. This groundbreaking approach to handling eggs and embryos allows clinics to leverage the latest advancements in IVF technology made by embryologists.

Tome Biosciences is a biotechnology company that specializes in programmable gene insertion technology. They facilitate the insertion of genetic sequences of any size into any location within a genome, aiming to identify and eliminate DNA from similar bacteriophages during future infections. This innovative approach enables patient cures through advanced cell and genome engineering techniques.

Tomorrow Health offers data-driven medical equipment sourcing services designed to simplify the ordering and access of home medical equipment for patients and their families. The company connects patients with suppliers based on factors such as insurance coverage, service quality, location, and product expertise. It streamlines the ordering process, manages insurance and logistics, and offers personalized support. Additionally, Tomorrow Health collaborates with health plans and hospital systems to help patients adhere to their care plans by removing burdensome paperwork and minimizing delivery delays.

TraceLink operates a network creation platform designed to digitize the entire supply chain process. The platform connects businesses and manages essential, multi-enterprise supply chain activities, helping to overcome organizational silos and significantly enhance resilience, cost efficiency, service quality, and predictability. This enables companies to integrate systems, procedures, and personnel into a unified information network for smart business management.

Transcarent is the developer of a health and care platform that is consumer-directed. It is designed to enable effective decision-making and better outcomes. The company utilizes a blend of software, technology stack, and data science to equip consumers with vital information. By directly linking them with an all-encompassing ecosystem of high-value providers and health services, Transcarent provides customers with the ability to make informed choices. This transparency addresses a wide array of challenges that are encountered in today's healthcare system.

Treeline Biosciences is a developer of groundbreaking precision medicines designed to combat cancer and other critical conditions. The company's platform leverages insights into normal and disease pathophysiology, experimental data, genomics, and pattern recognition to create transformative precision solutions for unmet patient needs. This approach empowers medical professionals to effectively treat cancer and other severe health issues.

Trialspark is the creator of a biotech platform that revolutionizes drug development to expedite patient treatments. The company's platform has expanded a network of trial sites by transforming existing practices into clinical trial locations with a mobile team of certified research coordinators, all enhanced by state-of-the-art software, data, and technology. This allows researchers to broaden their access to human subjects for research studies, paid clinical trials, psychological research, and focus groups.

Triveni Bio has developed a drug discovery platform focused on creating targeted therapies for immune and inflammatory (I&I) disorders. Utilizing a genetics-informed methodology, the company identifies patients who are most likely to benefit from their treatments, enhancing precision and minimizing trial and error. This approach helps in advancing the development of novel therapies that are more effective and less toxic than existing options, ultimately providing patients with improved treatment outcomes.

TrueBinding, a developer of antibody drugs, creates treatments intended for applications in immune-oncology and other disease areas. Their drugs provide novel ligands to receptors of documented checkpoint inhibitor pathways and an artificial intelligence and big data-driven platform. They offer services to their clients, including anti-cancer immunotherapy and targeted antibody drug delivery.

Truepill, a developer of a telehealth platform, is designed to construct, administer, and expand the pharmacy experience. Truepill's technology provides real-time insights into patients, prescriptions, and order specifics, and features numerous options for payment flexibility and delivery tracking. This enables healthcare professionals to enhance their patients' experiences and provide care that is both convenient and easily accessible.

Twin has developed a precision health platform aimed at diagnosing and repairing metabolic issues in diabetic patients. The platform leverages artificial intelligence, the internet of things, and digital technologies to identify metabolic dysfunction. By combining data, employing a unique digital twin AI technology, and utilizing insights from a clinical care team, Twin creates a comprehensive understanding of each patient's metabolism. This approach allows for the targeted repair of metabolic damage, which is the primary cause of diabetes, enabling healthcare professionals to craft personalized treatment plans for diabetic patients.

Two Chairs operates as a mental health platform with the mission of making exceptional mental health care universally accessible. The platform uses an innovative strategy by carefully matching patients with ideal therapists through a research-backed process. Additionally, it employs a leading measurement-based care system to accelerate patient improvement, making it easier for patients to find the right therapists.

Umoja Biopharma is a provider of advanced immunotherapies designed to revolutionize cancer treatment and enhance patient quality of life. The company's innovative cellular immunotherapy platform employs gene therapy to specifically target cancer cells. This platform can be delivered to any patient, with any type of tumor, at any given time. It works by directly, safely, and controllably attacking cancer, which empowers healthcare professionals to protect patients by generating and harnessing a robust immune response within the body.

Unite Us develops a care coordination and outcome-tracking platform that connects healthcare and social service providers. The platform enables providers to send and receive secure referrals, monitor each individual's comprehensive health journey, and report on measurable outcomes across various services within a unified, collaborative ecosystem. This allows clients to effectively measure impact, enhance health outcomes, and track results on a large scale.

Unlearn develops machine-learning models that generate digital twins to populate intelligent control arms in clinical trials. By using AI to create synthetic patient data, the company's technology speeds up clinical studies by supplementing control groups. This approach reduces the time needed to develop new medications, allowing healthcare companies to deliver life-saving therapies to patients more swiftly.

Upstream Bio Inc, a clinical-stage biotechnology company, is focused on developing treatments for inflammatory diseases, particularly severe respiratory disorders. Its lead product, verekitug, is an antagonist in clinical development targeting the receptor for Thymic Stromal Lymphopoietin (TSLP). This cytokine is a validated driver of inflammatory responses and impacts various immune-mediated diseases by acting upstream of multiple signaling pathways.

Valo is a health tech platform developer dedicated to streamlining the process of drug discovery and development. The platform leverages machine learning, cloud computing, and data to examine human data, revealing unexpected connections between genetic markers and disease through a human-focused lens. This enables healthcare industry clients to formulate drugs for oncology, neurodegenerative, and cardiovascular diseases.

Vanqua Bio is a biopharmaceutical company dedicated to creating innovative treatments for neurodegenerative diseases. The company specializes in discovering small-molecule activators of glucocerebrosidase and developing advanced programs aimed at the innate immune system, which can hasten the progression of various neurological conditions. This enables healthcare providers to improve patient outcomes with cutting-edge treatments for a range of disorders.

Verana Health is an operator of a data insights platform that aims to fast-track healthcare innovation and enhance drug and device development. The platform leverages regulatory-grade data sets to discover new market opportunities, improve trial design and recruitment, gain competitive intelligence to measure commercial success, and focus marketing efforts, among others. This empowers life science companies to make knowledge-based decisions using data from clinical specialty databases.

Verse Medical develops healthcare software designed to deliver dependable, timely, and cost-effective care for patients within their homes. Their platform provides a strong framework to facilitate the shift from hospitals to homes or from outpatient centers to home environments, allowing patients to experience seamless in-home care. It also aids healthcare administrators and clinicians in saving time.